Anthropic’s bankers are considering raising the company’s IPO valuation to $1.5 trillion or more, Bloomberg wrote on 11 November, relaying a Financial Times report. The FT, citing five people familiar with the matter, said bankers “have indicated they expect to raise the share price above the $US70-$US78 range announced in a filing early on Tuesday”.
The filing itself prices that change. Anthropic’s S-1/A of 10 November says each $1.00 move in the assumed price would change the net proceeds from the IPO and the concurrent private placement by approximately $793 million. On that sensitivity, a price of about $83, the level that matches $1.5 trillion on the FT’s fully diluted basis, gives Anthropic about $91.7 billion of net proceeds, against $84.6 billion at the $74.00 midpoint, by our arithmetic.
Business Pill · IPO Float
A short explainer on IPO float, the share of a company sold in its listing. It teaches the general idea and does not discuss Anthropic’s offering.
The key insight: As we read the filing, the reported price talk is a proceeds story first: Anthropic’s S-1/A says each $1.00 on the assumed price moves net proceeds by approximately $793 million, so the about $83 a share that matches the FT’s $1.5 trillion would mean about $91.7 billion for Anthropic, against $84.6 billion at the $74.00 midpoint, by our arithmetic.
As syndicated by the Australian Financial Review, the FT’s report opens: “Anthropic’s bankers are weighing plans to increase the AI group’s initial public offering price after receiving heavy demand from investors, less than a day after disclosing that it would target a $US1.4 trillion ($2 trillion) valuation when it lists next week”. It says a higher price “could increase the valuation target to $US1.5 trillion ($2.2 trillion) or more in the coming days”. We read the first two paragraphs; the rest is paywalled.
Summaries of the rest of the FT article add detail. Seeking Alpha writes that underwriters led by Goldman Sachs and Morgan Stanley “may increase the proposed share price above the $70-$78 range”, and that the filing “implied a valuation of between $1.26T and $1.41T on a fully diluted basis”. It adds that Anthropic “has prioritized maximizing proceeds from the listing to help fund its substantial computing infrastructure spending rather than focusing primarily on achieving the highest possible valuation”, citing three of the company’s backers.
Moneycontrol’s summary of the FT says “A higher offer price could push the combined fundraising package beyond $100 billion”, and that the FT reported a venture capital group “offering $1.25 billion in shares through a special-purpose vehicle at a $1.5 trillion valuation”. Morningstar’s fair equity value of $1.7 trillion, with a range of $500 billion to $3 trillion, is also in that summary. Bloomberg described the report as “a sign of robust demand”.
Net proceeds to Anthropic from the IPO and the $26.0 billion placement, and the 825 million IPO shares at gross, at the filed $70, $74 and $78 prices and at about $83, the price that matches the $1.5 trillion valuation the FT reported on its fully diluted basis. The $84.6 billion midpoint and the $793 million per $1.00 sensitivity are from the S-1/A of 10 November 2026; the rest is our arithmetic.
What the Filing Says a Higher Price Buys
The S-1/A sets the range: “It is currently estimated that the initial public offering price per share will be between $70.00 and $78.00”. Anthropic sells 801,351,354 shares and selling stockholders sell 23,648,646, for 825,000,000 in all, with an underwriters’ option on 123,750,000 more. Seven strategic investors buy “an aggregate of $26.0 billion of our Class N common stock” at the IPO price.
At the $74.00 midpoint, the filing estimates net proceeds from the IPO and the placement of approximately $84.6 billion, or approximately $93.7 billion with the underwriters’ option exercised in full. It adds that “The net proceeds we receive in the concurrent private placement are a fixed dollar amount and will not change with the initial public offering price”; only the number of placement shares moves.
Our Numbers
Dividing $1.5 trillion by the FT’s fully diluted value at $78, $1.41 trillion, gives about $83 a share, about 6.4% above the top of the range, by our arithmetic. Applying the filing’s $793 million per $1.00 sensitivity from the midpoint, net proceeds at $83 are about $91.7 billion, $7.1 billion more than at $74 and $4.0 billion more than at $78, by our arithmetic. The filing gives the sensitivity only for moves from the $74.00 midpoint; extending it to $83 is our assumption.
On gross figures, the 825,000,000 shares sell for $57.75 billion at $70 and $64.35 billion at $78; at $83 they would sell for about $68.5 billion, by our arithmetic. Adding the $26.0 billion placement and the full 123,750,000-share option gives about $100.0 billion at $78 and about $104.7 billion at $83, by our arithmetic.
On the shares the filing expects outstanding after the offering, with the placement share count recomputed at each price, $83 gives a market value of about $1.08 trillion, against about $918 billion at $70 and $1.02 trillion at $78, by our arithmetic. Our range piece sets out the two share bases; its update put $1.5 trillion at about $83.08 a share on its own fully diluted count.
The Structural Read
As we read the filing, the $26.0 billion placement is fixed in dollars, so a higher price raises the cash from the IPO shares while the placement buyers receive fewer shares for the same money.
As we read the reports, the two figures move together: the summaries of the FT say Anthropic has prioritized maximizing proceeds over the highest possible valuation, and on the filing a higher price raises both.
Anthropic, PBC, Form S-1/A, 10 November 2026
“The net proceeds we receive in the concurrent private placement are a fixed dollar amount and will not change with the initial public offering price”
Three Implications
FOR THE RAISE At about $83, the 825,000,000 IPO shares, the full underwriters’ option and the $26.0 billion placement add up to about $104.7 billion, against about $100.0 billion at $78, by our arithmetic.
FOR THE SHARE COUNT On the shares the filing expects outstanding, $83 corresponds to a market value of about $1.08 trillion, by our arithmetic; the $1.5 trillion figure is on the FT’s fully diluted basis.
FOR THE RECORD Any new range would appear in a new SEC filing; our 08:07 GMT check found the 10 November S-1/A still the latest.
The framework records: “the capex race is no longer a corporate spending cycle. It is a sovereign-scale financing problem dressed in tech-company clothing”.
As we read it, an IPO priced for proceeds is one instance of that financing problem: the summaries of the FT say the cash is meant to help fund computing infrastructure spending. The framework predates the filing and does not discuss this IPO.
What Is Not Established
No new price range has been filed. Our check of Anthropic’s EDGAR filings at 08:07 GMT on 11 November listed the 10 November S-1/A as the latest filing, with no newer amendment or free writing prospectus. The FT described plans being weighed, citing people familiar with the matter; the new price, its timing and the size of investor orders are not established in the parts we read. The Seeking Alpha and Moneycontrol passages are their summaries of the FT, not text we read in the FT itself.
The Great Convergence of Capital, Power, and Geopolitics
This week’s issue: for two years the AI build-out was priced as a supply story, and last week as a credit story. This week it was priced as a permission story, and the answer arrived as a cost, not a ban.
The FT reports, citing five people familiar with the matter, that Anthropic’s bankers expect to raise the share price above the filed $70 to $78 range, which the FT says could lift the valuation target to $1.5 trillion or more; that is about $83 a share on the FT’s fully diluted basis, by our arithmetic. The S-1/A says each $1.00 on the price moves net proceeds by about $793 million, so a price of $83 would mean about $91.7 billion for Anthropic, $7.1 billion above the midpoint, by our arithmetic.
A note on sourcing. The report is the Financial Times’s, which is paywalled: we read its headline and its first two paragraphs as syndicated by the Australian Financial Review, Bloomberg’s newsletter item relaying it, and the Seeking Alpha and Moneycontrol summaries named in the text. Filing figures and quotations are from Anthropic’s S-1/A filed with the SEC on 10 November 2026. The prices, proceeds and market values not quoted from the filing are our arithmetic. Anthropic was not contacted for this piece.
Gennaro Cuofano is a CRO and tech executive who has worked in AI since late 2015, starting with bringing NLP, natural-language generation, voice and chatbot products to the marketing industry. His background is in law and finance: he holds a Master's degree in Law and an International MBA with an emphasis on corporate finance (LUISS Business School and the University of San Diego, 2012), and worked as a financial analyst at a real-estate investment firm in San Diego and as an assistant controller. His work focuses on business model strategy, business engineering and, more broadly, structural analysis: how companies make money, read from their own filings. He created FourWeekMBA and leads research there and at The Business Engineer, his newsletter on AI and business strategy, with over 95,000 subscribers and more than 1,000 published analyses. His writing has also appeared on Entrepreneur (for example, How to Digitize a Family Business in Europe) and HackerNoon. Find him on LinkedIn and Substack. See how we source.
